EGRP News Flash - April 10, 2008
NIH Seeks Info on Pharmacogenomics by April 20th
We thought you might be interested in an opportunity to
respond to a Request for Information (RFI) on challenges and barriers
to pharmacogenomics research. The request is from the Trans-NIH Pharmacogenomics
Working Group. The RFI is in the form of an on-line series of questions
intended to reveal gaps and highlight opportunities in pharmacogenomics,
and to aid in identifying specific, achievable goals that will advance
and transform the field overall. NIH wants to consider research needs
from discovery-based efforts to validation and applied research,
in order to accelerate the translation of pharmacogenomics discoveries
into the clinical realm.
NIH is interested in responses that suggest
transformative ideas and approaches. The best ideas will have great
potential to dramatically affect how biomedical research is conducted
over the next decade, yet will be concrete and achievable tasks.
Moreover, NIH wants to leverage existing research mechanisms and
resources. Ideas for enabling research efforts of interest would
be those challenges to pharmacogenomics that: (1) are activities
that no other entity is likely to be able to successfully conduct,
(2) will generate knowledge that can be made publicly accessible,
and (3) are of clear benefit to public health.
Responses must be
submitted electronically at http://www.nigms.nih.gov/Initiatives/NIH-RFI and
will be accepted through April 30, 2008.
Contact: Rochelle M. Long,
Ph.D., Chief, Pharmacology & Physiological Sciences Branch; Pharmacology,
Physiology, & Biological Chemistry Division, National Institute
of General Medical Sciences (NIGMS), e-mail: Rochelle.long@nih.gov.
Access the NIH Guide for Grants and Contracts for details:
NOT-GM-08-125.
Subscribe to EGRP Bulletins and News Flashes
You are welcome to invite
others to subscribe to receive occasional Bulletins and News
Flashes from the Epidemiology and Genetics Research Program (EGRP).
|
